Literature DB >> 27496392

Health professional advice, use of medications and smoking cessation: A population-based prospective cohort study.

Bo Zhang1, Michael O Chaiton2, Lori M Diemert2, Susan J Bondy2, K Stephen Brown3, Roberta Ferrence4.   

Abstract

INTRODUCTION: The mediating role of cessation medications in the association between health professional advice and quitting behaviors is unclear.
METHODS: Data were from the Ontario Tobacco Survey longitudinal study, collected between July 2005 and June 2011 in Ontario, Canada. The analytic sample included 3437 baseline smokers who were seen by health professionals during follow-up. Logistic regression with generalized estimating equations and mediation analysis techniques were used to examine the impact of advice and medications on quitting outcomes (making a quit attempt, short-term quitting 1-6months and long-term quitting>6months).
RESULTS: Those who received advice to quit smoking were more likely to use cessation medications than those who did not receive advice (21% vs. 13%, P<0.001). Receiving advice was associated with making a quit attempt (adjusted odds ratio (OR) 1.25, 95% confidence interval (CI) 1.10-1.41) and long-term quitting (adjusted OR 1.49, 95% CI 1.10-2.02), but not with short-term quitting. Use of cessation medications was associated with making a quit attempt (adjusted OR 11.83, 95% CI 9.93-14.08), short-term quitting (adjusted OR 3.69, 95% CI 2.90-4.68), and long-term quitting (adjusted OR 2.73, 95% CI 1.95-3.82). Using prescription medications was associated with a higher likelihood of quitting short-term (adjusted OR 2.43, 95% CI 2.59-3.74) and long-term (adjusted OR 2.27, 95% CI 1.23-4.17) than using NRT. Use of cessation medications was a significant mediator in the pathway from receiving advice to quitting.
CONCLUSION: Health professionals should advise smokers to quit and encourage them to use cessation medications, especially prescription medications when trying to quit.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cohort study; Health professional advice; Mediation analysis; Medications; Smoking cessation

Mesh:

Substances:

Year:  2016        PMID: 27496392     DOI: 10.1016/j.ypmed.2016.07.027

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  5 in total

1.  History and Correlates of Smoking Cessation Behaviors Among Smokers With Serious Mental Illness.

Authors:  Su Fen Lubitz; Alex Flitter; E Paul Wileyto; Douglas Ziedonis; Nathaniel Stevens; Frank Leone; David Mandell; John Kimberly; Rinad Beidas; Robert A Schnoll
Journal:  Nicotine Tob Res       Date:  2020-08-24       Impact factor: 4.244

2.  The Effect of a Pilot Pediatric In-Patient Department-Based Smoking Cessation Intervention on Parental Smoking and Children's Secondhand Smoke (SHS) Exposure in Guangxi, China.

Authors:  Kaiyong Huang; Li Yang; Jonathan P Winickoff; Jing Liao; Guangmin Nong; Zhiyong Zhang; Xia Liang; Gang Liang; Abu S Abdullah
Journal:  Int J Environ Res Public Health       Date:  2016-11-08       Impact factor: 3.390

Review 3.  The effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature review.

Authors:  Raewyn Rees; Ali Seyfoddin
Journal:  J Pharm Policy Pract       Date:  2017-07-11

4.  Retrospective reports of former smokers: Receiving doctor's advice to quit smoking and using behavioral interventions for smoking cessation in the United States.

Authors:  Yujiao Mai; Julia N Soulakova
Journal:  Prev Med Rep       Date:  2018-07-29

5.  Tobacco smoking and nicotine delivery alternatives: patterns of product use and perceptions in 13 countries.

Authors:  Farhad Riahi; Sarah Rajkumar; Derek Yach
Journal:  F1000Res       Date:  2019-01-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.